Vesting and Award of Options under LTIP

Summary by AI BETAClose X

Abingdon Health plc announced updates regarding its Long Term Incentive Plan (LTIP), with 16% of FY23 LTIPs vesting based on FY25 revenue and EBITDA targets, resulting in 512,800 options vested at a 7 pence exercise price, while 2,692,199 LTIP shares lapsed. Additionally, new nil-cost LTIPs totaling 3,361,000 shares have been awarded, vesting around October 2028, contingent on achieving FY28 revenue and EBITDA targets. The total outstanding LTIP share options, after accounting for lapsed FY23 options, stand at 10,090,570, representing 3.86% of ordinary shares post-exercise.

Disclaimer*

UK 100

Latest directors dealings